These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12702128)

  • 1. An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment use.
    Sabin CA; Lampe FC; Chaloner C; Madge SJ; Lipman MC; Youle M; Phillips AN; Johnson MA
    HIV Med; 2003 Apr; 4(2):87-93. PubMed ID: 12702128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve.
    Street E; Curtis H; Sabin CA; Monteiro EF; Johnson MA;
    HIV Med; 2009 Jul; 10(6):337-42. PubMed ID: 19490183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort.
    Gerver SM; Chadborn TR; Ibrahim F; Vatsa B; Delpech VC; Easterbrook PJ
    J Int AIDS Soc; 2010 Aug; 13():29. PubMed ID: 20684760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An audit of HIV treatment outcomes in a UK inner city cohort.
    Bird E; Cormack I; Rodgers M; Phillips D; Elgalib A
    Int J STD AIDS; 2016 Oct; 27(12):1114-1116. PubMed ID: 27147265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic.
    Carmody ER; Diaz T; Starling P; dos Santos AP; Sacks HS
    Trop Med Int Health; 2003 May; 8(5):378-85. PubMed ID: 12753630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.
    Cunningham WE; Markson LE; Andersen RM; Crystal SH; Fleishman JA; Golin C; Gifford A; Liu HH; Nakazono TT; Morton S; Bozzette SA; Shapiro MF; Wenger NS
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):115-23. PubMed ID: 11103041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with 10 years of continuous viral load suppression on HAART.
    Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
    BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
    Sterling TR; Chaisson RE; Moore RD
    AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study.
    Sabin CA; Hill T; Lampe F; Matthias R; Bhagani S; Gilson R; Youle MS; Johnson MA; Fisher M; Scullard G; Easterbrook P; Gazzard B; Phillips AN;
    BMJ; 2005 Mar; 330(7493):695. PubMed ID: 15749728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric antiretroviral therapy audit in South London.
    Doerholt K; Sharland M; Ball C; DuMont G
    HIV Med; 2002 Jan; 3(1):44-8. PubMed ID: 12059950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.
    Djomand G; Roels T; Ellerbrock T; Hanson D; Diomande F; Monga B; Maurice C; Nkengasong J; Konan-Koko R; Kadio A; Wiktor S; Lackritz E; Saba J; Chorba T
    AIDS; 2003 Jul; 17 Suppl 3():S5-15. PubMed ID: 14565604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audit of antiretroviral medication offered to patients with HIV attending a district general hospital for outpatient care.
    Ivens D; Brook G
    Int J STD AIDS; 2000 Mar; 11(3):193-5. PubMed ID: 10726946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An audit of HIV care in English prisons.
    Chan SY; Marsh K; Lau R; Pakianathan M; Hughes G
    Int J STD AIDS; 2015 Jun; 26(7):504-8. PubMed ID: 25080291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).
    Holodniy M; Hornberger J; Rapoport D; Robertus K; MaCurdy TE; Lopez J; Volberding P; Deyton L
    J Acquir Immune Defic Syndr; 2007 Jan; 44(1):20-9. PubMed ID: 17091020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings from the first national clinical audit of treatment for people with HIV.
    Curtis H; Sabin CA; Johnson MA;
    HIV Med; 2003 Jan; 4(1):11-7. PubMed ID: 12534954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.